NK:IO raises £1.2M, bringing total Seed funding to £5.1M, to advance pioneering NK cell therapy
NK:IO, a leader in natural killer (NK) cell biology applied to the development of exceptionally potent, off-the-shelf cell therapies targeting solid tumours, has raised £1.2M.
D-CYPHR goes live across the UK
Largest ever DNA and health research programme for children and young people launches to tackle toughest health challenges – through the power of spit.
Qureight collaborates with AstraZeneca on lung disease research
Cambridge-based data analytics company Qureight has entered into a multi-year collaboration with biopharmaceutical company AstraZeneca.
Revvity establishes Scientific Centre of Excellence for Genomic Insight in Cambridge
Global health science solutions company Revvity, Inc., has announced the establishment of a Scientific Centre of Excellence in Cambridge, UK. Focused on driving genomic insights to accelerate therapeutic discovery, Revvity’s Scientific Centre of Excellence supports the Company’s fundamental commitment to expanding boundaries in pursuit of a better future for human health.
AudioTelligence breaks new ground in Assistive Tech with Earbud Assistive Listening Case
AudioTelligence announces its innovative new product concept, which for the first time integrates assistive listening technology into an earbud charging case. This world-first combination of hearing technology with earbud charging facilities provides manufacturers with a comprehensive all-in-one solution for individuals with hearing impairments as well as for anyone who needs to hear clearly in…
Cambridge Enterprise celebrates a year of innovation and economic growth
Cambridge Enterprise, the research commercialisation arm of the University of Cambridge, marked its 15th anniversary with a remarkable series of achievements.
Plans submitted for the redevelopment of The Grafton centre in Cambridge
Plans to turn The Grafton into a new research hub for the life science sector have been submitted to Cambridge City Council, Cambridge Independent reports. Developers plan to convert much of the declining shopping mall into laboratory space, while turning the western end into a more attractive destination for shoppers.
How to lead when you answer to experts?
Rise Above is streaming episode #9 in their series Leading Conversations.
Cambridge Filmworks share Genomics England: Owen’s Story
Owen lives with a rare genetic thyroid condition. In this new film from Cambridge Filmworks, Owen’s parents Sarah and Rob share how life has changed for their family in the nearly 5 years since the diagnosis through whole genome sequencing and the 100,000 Genomes Project.
Celebrating our Centres - Maudsley
This week we hear from the team at NIHR BioResource Centre London Maudsley about what they’ve been up to post-pandemic. Volunteer recruitment, research studies, and community events are just a few to name alongside an exciting new initiative being launched in collaboration with the NIHR BioResource to promote research in black communities.
John Hicks Co Ltd announces new training course for managers in Bioscience and Healthcare
The new one day training course is for new managers within Bioscience and Healthcare, that seek to develop their personal resilience in the face of challenge.
NIHR BioResource celebrate Newcastle centre
To kick off the new series of articles celebrating regional BioResource Centres, the team interviewed Newcastle’s IMID/NAFLD Project Coordinator Amber Ali about her role opening over 60 recruitment sites over the past couple years, as well as a general update on what the Newcastle Centre team have been up to since the pandemic.
Corazon Health reaches Cambridge Independent SME Cambridgeshire Business Awards Final 2023
Corazon Health, Cambridge-based occupational health service, are thrilled to announce that Corazon Health has reached the Cambridge Independent SME Cambridgeshire Business Awards Final 2023 in the Website of the Year category.
ARMGO Pharma Enrolls First Patient in Phase 2 Trial of ARM210 for the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia
Trial to investigate the safety and efficacy of ARM210 for the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) Lead molecule ARM210 repairs ‘leaky’ Ryanodine Receptor (RyR) channels to restore intracellular calcium signaling in cardiac and mH.E.L Group signs agreement with Indian Institute of Technology (IIT) Kanpur in national initiative for sustainable energy
H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, safety, and scale-up, today announced it has signed an agreement with the Indian Institute of Technology Kanpur (IIT Kanpur), a prestigious Indian academic institution kickstarting scientific and technological research. The collaboration is part of a national initiative in sustainable…
Arrayjet announces collaboration with Chemspace to augment its small molecule microarray services for drug discovery
Arrayjet, a leading provider of inkjet liquid-handling solutions, today announced that it has partnered with Chemspace, the largest online catalogue of small molecules and biologics, to augment and streamline the Company’s small molecule microarray (SMM) service offering. Chemspace’s curated and deeply annotated compound libraries are now accessible through Arrayjet’s SMM CRO/CMO services for…
Recap of the first NIHR BioResource Scientific Conference 2023
On 28 June 2023, we held our first NIHR BioResource Scientific Conference – find out more about how it went, the topics discussed and the feedback we received!
Nitrite screening in the Pharmaceutical Industry: The Power of the ATNA System
In the world of pharmaceutical manufacturing and quality assurance, nitrites have been identified as a considerable concern.
PhoreMost appoints Professor Peter Parker and Dr Jason Imbriglio to Scientific Advisory Board
Experts in translational oncology and targeted protein degradation join Dr Simon Cook, Dr Lorenz Mayr and Dr Catherine Beech to provide scientific and strategic oversight
Corazon Health's OHA Days took place last week
Last week Corazon Health celebrated their OHA Days - an annual event which aims to provide additional training to employees through workshops, debates and question-and-answer sessions.
Office of Life Sciences Healthtech Survey
The impact that the HealthTech industry has on patients, and health systems, is well recognised. But its economic footprint, through the creation of high quality jobs, and vibrant regional clusters, is less understood.
A full house at eighth Milner Therapeutics Symposium
The Milner Therapeutics Institute celebrates the success of its eight annual Symposium, held at West Road Concert Hall on 5th July.
Team Consulting host new lunch&learn series
This July, Team Consulting is offering a series of free lunchtime webinars to provide key insights into the world of medical device development. Running from the 10th to 20th of July, the webinars will cover some of the latest industry trends, from sustainability analysis to how medical devices are closing the gender health gap.
Imperial spinout NK:IO awarded £1.6M Innovate UK New Cancer Therapeutics grant for development of pioneering NK cell therapy
Grant award of £1.6M supports program of development work with Cell and Gene Therapy Catapult NK:IO’s platform, based on pioneering discoveries in NK cell biology, yields industry-leading tumour killing and cell productionLarge amounts of capital still to be deployed in life sciences sector, says RSM UK
Private equity buyouts in the UK healthcare sector including life sciences increased 14%* in Q1 2023 and remain ahead of pre-pandemic levels, even in the face of economic headwinds. With high levels of capital available to be deployed, its expected private equity interest will continue to be elevated, says RSM UK.